20 year healthcare/biotech professional. Strong background in negotiating licenses, JV's, and partnering arrangements leading to operating and royalty-based revenues. Built strong professional teams. Sold and bought operating divisions and companies, took one firm public. Five years at Merck; 4 at Talecris Biopharmaceuticals (Cerburus owned); former President, MorphySys USA. BA, Harvard; MBA UNC-Chapel Hill

Senior financial professional with 25 years experience in finance, law, and fast-growing companies. Established accounting and control systems for early stage tech companies as CFO and Board member. Solid background in VC finance, including biotech companies involved in stem cells. Strong presentation and analytical skills. Core prof'l experience as Wall Street atty and investment banker. BA, Johns Hopkins; JD, UCLA; MBA, Stanford.

Dr. Claudio has 20 years of experience in cancer research and targeted therapy. He has published over 120 scientific articles and holds numerous patents.

He is Assoc. Professor, Marshall Univ School of Medicine, and also serves as Dir. of the Translational Genomics Research Institute. He graduated from the Univ. of Naples (Italy) and has been an Assoc. Professor at Jefferson Univ. Med School, and Director, Temple Univ. Molecular Therapy Prog

Dr. Valluri is Professor of Cellular Biology and Integrative Medicine at Marshall University. He has over 21 years of research experience in cell culture, production of anticancer bio-molecules,and bench-top fermenters. Dr. Valluri has consulted to NASA and U.S. Army Corps of Engineers and is the author of several journal articles, book chapters and co-inventor on 2 patent apps. He earned his Ph.D. in Molecular Biology from Texas A & M Univ.